Elsevier

The Lancet

Volume 343, Issue 8910, 4 June 1994, Pages 1394-1396
The Lancet

Short reports
Recessive inheritance of erythropoietic protoporphyria with liver failure

https://doi.org/10.1016/S0140-6736(94)92525-9Get rights and content

Abstract

Erythropoietic protoporphyria is characterised by skin photosensitivity and deficiency of ferrochelatase; fatal liver disease occurs rarely. Transmission is considered to be dominant with incomplete penetrance. We investigated a family in which two siblings with erythropoietic protoporphyria developed hepatic failure that required transplantation. Their healthy parents had partial enzyme deficiency and were each heterozygous for a distinct mutation in a ferrochelatase gene. Both offspring were compound heterozygotes with ferrochelatase deficiency. Recessive transmission of protoporphyria predisposes to severe liver disease in this family. Patients with the recessive form of this disease may be at special risk of hepatic failure.

Cited by (86)

  • Diagnosis and treatment of icteric hepatitis caused by erythropoietic protoporphyria: A case report

    2022, Liver Research
    Citation Excerpt :

    Erythropoietic protoporphyria (EPP, MIM 177000) manifests pseudodominant inheritance owing to ubiquitous loss-of-function polymorphisms in the intron and should be better recognized as recessive inheritance.1–4

  • Protoporphyria

    2012, The Porphyrin Handbook: Medical Aspects of Porphyrins
  • Seasonal palmar keratoderma in erythropoietic protoporphyria indicates autosomal recessive inheritance

    2009, Journal of Investigative Dermatology
    Citation Excerpt :

    To date we have not seen a patient with keratoderma who has not had recessive EPP but more patients need to be studied before the reliability of palmar keratoderma as a clinical indicator of recessive EPP can fully be assessed. Keratoderma was not reported as a clinical feature of either dominant or recessive EPP (Schmidt et al., 1974; DeLeo et al., 1976; Lamoril et al., 1991; Todd, 1994; Sarkany et al., 1994a; Poh-Fitzpatrick et al., 2002; Gouya et al., 2006) before our study of 223 UK patients with this disorder (Holme et al., 2006); possibly because it is uncommon and, unless large numbers of patients are investigated, the association of EPP with keratoderma may be regarded as chance, as was initially the case for two of our families. However, it seems unlikely that keratoderma has been overlooked in all previously reported patients with recessive EPP.

  • Production and characterization of erythropoietic protoporphyric heterodimeric ferrochelatases

    2005, Blood
    Citation Excerpt :

    Patients with 50% residual activity are usually not symptomatic. During the past 2 decades, several hypotheses have been forwarded to explain this observation, including a 3-allele, autosomal recessive hypothesis.9,10 Data currently available support a model by which clinical EPP and the 10% to 30% residual ferrochelatase activity result when a patient has an EPP mutant allele along with one wild-type allele that is a low-expression allele.

View all citing articles on Scopus
View full text